Functional expression of B7/BB1 on activated T lymphocytes
- PMID: 7679711
- PMCID: PMC2190946
- DOI: 10.1084/jem.177.3.845
Functional expression of B7/BB1 on activated T lymphocytes
Abstract
B7/BB1 is a membrane differentiation antigen expressed on activated B cells, macrophages, and dendritic cells that binds to a counter-receptor, CD28, expressed on T lymphocytes and thymocytes. Interaction between CD28 and B7 results in potent costimulation of T cell activation initiated via the CD3/T cell receptor complex. We now report that B7 is also expressed on activated human peripheral blood T cells, CD4 T cell clones, CD8 T cell clones, and natural killer cell clones. B7 appears relatively late after T cell activation, can be detected on both CD4 and CD8 T cell subsets, and is present on antigen-specific, major histocompatibility complex-restricted CD4 and CD8 T cell clones. Expression of B7 on activated T cells was confirmed by immunoprecipitation from 125I-labeled activated T cells and by detection of B7 transcripts. A B7+ CD4+ T cell clone was able to stimulate a primary allogeneic mixed lymphocyte response using small, resting peripheral blood T cells as responders. The alloantigen-induced proliferative response and cytokine production was partially inhibited by anti-B7 monoclonal antibody. Since activated T cells can coexpress both CD28 and its counter-receptor, B7, this suggests that activated T cells may be capable of autocrine costimulation via the CD28 activation pathway.
Similar articles
-
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.J Exp Med. 1992 Feb 1;175(2):353-60. doi: 10.1084/jem.175.2.353. J Exp Med. 1992. PMID: 1370679 Free PMC article.
-
The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.J Exp Med. 1991 Mar 1;173(3):759-62. doi: 10.1084/jem.173.3.759. J Exp Med. 1991. PMID: 1847724 Free PMC article.
-
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.J Exp Med. 1993 Jan 1;177(1):165-73. doi: 10.1084/jem.177.1.165. J Exp Med. 1993. PMID: 7678111 Free PMC article.
-
The B7-CD28 superfamily.Nat Rev Immunol. 2002 Feb;2(2):116-26. doi: 10.1038/nri727. Nat Rev Immunol. 2002. PMID: 11910893 Review.
-
The role of B7 costimulation in T-cell immunity.Immunol Cell Biol. 1999 Aug;77(4):304-11. doi: 10.1046/j.1440-1711.1999.00835.x. Immunol Cell Biol. 1999. PMID: 10457196 Review.
Cited by
-
Intercellular Transfer of Immune Regulatory Molecules Via Trogocytosis.Results Probl Cell Differ. 2024;73:131-146. doi: 10.1007/978-3-031-62036-2_6. Results Probl Cell Differ. 2024. PMID: 39242377 Review.
-
Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.Immunology. 1995 Oct;86(2):155-61. Immunology. 1995. PMID: 7490112 Free PMC article.
-
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.J Exp Med. 1994 Nov 1;180(5):1841-7. doi: 10.1084/jem.180.5.1841. J Exp Med. 1994. PMID: 7525840 Free PMC article.
-
T cells as vehicles for cancer vaccination.J Biomed Biotechnol. 2011;2011:417403. doi: 10.1155/2011/417403. Epub 2011 Oct 27. J Biomed Biotechnol. 2011. PMID: 22131805 Free PMC article. Review.
-
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.Clin Exp Immunol. 1995 Jun;100(3):425-33. doi: 10.1111/j.1365-2249.1995.tb03717.x. Clin Exp Immunol. 1995. PMID: 7539725 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous